13F Data
13F filer · CIK 1674546

Bellevue Group AG

ZURICH, V8 · filing since Q1 2016 · last filing Aug 14, 2026
Reported value
$4.8B
+$550.7M vs prior
Positions
148
New / sold out
17 / 24
Added / reduced
41 / 66
Turnover
23.5%
buys $1.1B · sells $1.1B
Top-10 weight
42.9%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedAMGEN INC+556,192+188.3%+$201.4M
AddedINSMED INC+1,383,384+13787.0%+$147.5M
AddedGILEAD SCIENCES INC+988,893+84.5%+$124.9M
AddedORUKA THERAPEUTICS INC+1,150,182+226.9%+$109.5M
AddedUNITED THERAPEUTICS CORP DEL+186,438+8976.3%+$101.0M
AddedBRIDGEBIO PHARMA INC+1,164,129+4587.3%+$86.7M
AddedVAXCYTE INC+781,238+65.6%+$45.4M
NewAVALYN PHARMACEUTICALS INC+1,350,000–+$44.4M
NewCG ONCOLOGY INC+493,596–+$35.1M
NewSEAPORT THERAPEUTICS INC+1,100,000–+$23.9M
48 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedKRYSTAL BIOTECH INC-404,255-83.9%$-150.2M
ReducedREVOLUTION MEDICINES INC-496,442-32.1%$-93.0M
ReducedREGENERON PHARMACEUTICALS-121,383-43.6%$-75.7M
ReducedALNYLAM PHARMACEUTICALS INC-233,451-99.5%$-70.3M
ReducedIONIS PHARMACEUTICALS INC-846,407-46.5%$-67.1M
ReducedSCHOLAR ROCK HLDG CORP-1,135,026-31.7%$-62.4M
ReducedTANGO THERAPEUTICS INC-1,705,818-71.1%$-53.3M
ReducedVERTEX PHARMACEUTICALS INC-103,274-15.1%$-51.3M
Sold outEDGEWISE THERAPEUTICS INC-1,528,518-100.0%$-48.1M
ReducedENLIVEN THERAPEUTICS INC-830,867-35.8%$-42.2M
80 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q1 2016: $551.1MQ2 2016: $531.5MQ3 2016: $553.5MQ4 2016: $488.3MQ1 2017: $750.4MQ2 2017: $845.7MQ3 2017: $956.1MQ4 2017: $957.2MQ1 2018: $1.0BQ2 2018: $1.2BQ3 2018: $1.6BQ4 2018: $1.5BQ1 2019: $1.8BQ2 2019: $5.9BQ3 2019: $5.4BQ4 2019: $6.3BQ1 2020: $5.2BQ2 2020: $7.1BQ3 2020: $7.2BQ4 2020: $8.7BQ1 2021: $9.5BQ2 2021: $10.2BQ3 2021: $9.9BQ4 2021: $9.7BQ1 2022: $8.6BQ2 2022: $7.1BQ3 2022: $7.0BQ4 2022: $7.5BQ1 2023: $6.9BQ2 2023: $7.0BQ3 2023: $6.2BQ4 2023: $6.5BQ1 2024: $6.6BQ2 2024: $6.2BQ3 2024: $6.2BQ4 2024: $5.2BQ1 2025: $4.5BQ2 2025: $4.5BQ3 2025: $4.8BQ4 2025: $5.3BQ1 2026: $4.2BQ2 2026: $4.8B
Q1 2016Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1AMGEN INCCOM851,550$308.4M6.49%
2VERTEX PHARMACEUTICALS INCCOM578,634$287.4M6.05%
3ARGENX SESPONSORED ADR301,000$279.3M5.88%
4GILEAD SCIENCES INCCOM2,158,772$272.7M5.74%
5REVOLUTION MEDICINES INCCOM1,048,014$196.3M4.13%
6ORUKA THERAPEUTICS INCCOM1,657,190$157.7M3.32%
7INSMED INCCOM PAR $.011,393,418$148.6M3.13%
8SCHOLAR ROCK HLDG CORPCOM2,449,547$134.7M2.83%
9NUVALENT INCCOM1,053,268$130.1M2.74%
10VIRIDIAN THERAPEUTICS INCCOM6,731,909$123.7M2.60%
138 more rows. Subscribe for $29/month to see every row, download the data and use the API.